Long COVID research risks losing momentum – we need a moonshot

Dr. Michael Peluso (LIINC principal investigator) and Lisa McCorkell (co-founder of the Patient-led Research Collaborative) argue that investing US$1 billion every year for the next ten years into long COVID research could improve the lives of millions and save trillions in economic costs. This increase in funding could lead to better coordination between Long COVID researchers (who often have diverse backgrounds in medicine), identification of Long COVID biomarkers (proteins that can be used to diagnose Long COVID), development of more and larger clinical trials attempting to treat the condition, and shine more light on other infection-associated chronic conditions like myalgic encephalomyelitis (also known as chronic fatigue syndrome).